This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Keio University. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Innovations by Miyuki Tachibana
Introduction
Miyuki Tachibana is a notable inventor based in Kanagawa, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in developing compositions that target specific biological pathways.
Latest Patents
Miyuki Tachibana holds a patent for a pharmaceutical composition that inhibits the expression of iNOS and COX-2 without affecting NF-κB. This innovative composition includes DTCM glutarimide as an effective ingredient, which helps in reducing nitric oxide (NO) and prostaglandin production. Her work in this area has the potential to advance therapeutic options for various inflammatory conditions.
Career Highlights
Miyuki Tachibana is affiliated with Keio University, where she continues her research and development in pharmaceutical sciences. Her academic background and ongoing research contribute to her reputation as a leading figure in her field.
Collaborations
Miyuki has collaborated with esteemed colleagues such as Kazuo Umezawa and Yuichi Ishikawa. These partnerships enhance her research capabilities and broaden the impact of her innovations.
Conclusion
Miyuki Tachibana's work exemplifies the intersection of innovation and pharmaceutical research. Her contributions are paving the way for new therapeutic strategies in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile